Quick Answer
MapLight Therapeutics, Inc. reported Shares Outstanding of 44.02 million shares for fiscal year 2025.
MapLight Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 44.02M | +5682.9% |
| 2024 | 761,276 | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 808,015 | — | +6.1% |
| December 31, 2024 | 761,276 | — | — |
- MapLight Therapeutics, Inc. showed an increase of +5682.9% in Shares Outstanding compared to the prior fiscal year.
- Over the 2024–2025 period, MapLight Therapeutics, Inc.’s shares outstanding has grown by 5682.9% (from 761.3 thousand shares to 44.02 million shares).
- The most recent figure is from MapLight Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: